Söndag 22 December | 06:12:10 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-02-17 N/A Bokslutskommuniké 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-16 - Kvartalsrapport 2024-Q2
2024-06-07 - X-dag ordinarie utdelning POLYMER 0.00 SEK
2024-06-05 - Årsstämma
2024-05-08 - Kvartalsrapport 2024-Q1
2024-02-16 - Bokslutskommuniké 2023
2023-11-10 - Kvartalsrapport 2023-Q3
2023-08-16 - Kvartalsrapport 2023-Q2
2023-06-05 - X-dag ordinarie utdelning POLYMER 0.00 SEK
2023-06-02 - Årsstämma
2023-05-10 - Kvartalsrapport 2023-Q1
2023-02-15 - Extra Bolagsstämma 2023
2023-02-10 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-08-10 - Kvartalsrapport 2022-Q2
2022-06-09 - X-dag ordinarie utdelning POLYMER 0.00 SEK
2022-06-08 - Årsstämma
2022-05-10 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-12-20 - Extra Bolagsstämma 2021
2021-11-25 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-06-03 - Årsstämma
2021-05-25 - Kvartalsrapport 2021-Q1

Beskrivning

LandSverige
ListaNordic SME Sweden
SektorMaterial
IndustriPlast, kemikalier & fetter
Polymer Factory Sweden är specialiserade inom nanoteknologi. Bolaget utvecklar polymera material som används i diverse medicinska behandlingar. Lösningarna används huvudsakligen som komplement i olika behandlingar för cancer och neurologiska sjukdomar. Utöver huvudverksamheten erbjuder bolag kalibreringsteknik som används i olika analyser- och livsmedelstestning.
2023-02-01 15:17:55

In a recently published study by Zhang et al, dendritic nanogels (DNGs) show promising results as carriers of antimicrobial peptides (AMP) for topical treatment of skin infections. DNGs were made commercially available by Polymer Factory in December 2022.

The study was conducted with the aim of finding a topical delivery strategy for AMPs, which are promising antibacterial agents. AMPs were encapsulated in DNGs and subsequently embedded in a hydrogel, which formed the delivery system. In-vitro studies showed good biocompatibility and in-vivo models showed superior efficacy of the DNG-encapsulated AMPs compared to the AMP in solution.

The study was published in the journal Macromolecular Bioscience in January 2023. Find the link to the paper here (https://pubmed.ncbi.nlm.nih.gov/36639138/).

Find more information about Polymer Factory's DNGs here (https://www.polymerfactory.com/dendritic-nanogels).

*Note: The research that was conducted belonged to Prof. Michael Malkoch at KTH, the Malkoch Group, and was not influenced or sponsored by Polymer Factory. Prof. Malkoch is the CTO of Polymer Factory.